CROSS DISCIPLINE TEAM LEADER REVIEW
暂无分享,去创建一个
[1] M. Derrick,et al. Major neurological events following foam sclerotherapy , 2008, Phlebology.
[2] F. Allaert,et al. Immediate and Midterm Complications of Sclerotherapy: Report of a Prospective Multicenter Registry of 12,173 Sclerotherapy Sessions , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[3] F. Allaert,et al. Evaluation of the Efficacy of Polidocanol in the Form of Foam Compared With Liquid Form in Sclerotherapy of the Greater Saphenous Vein: Initial Results , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[4] B. Golomb,et al. Chronic venous disease in an ethnically diverse population: the San Diego Population Study. , 2003, American journal of epidemiology.
[5] M. Stacey,et al. The Australian Polidocanol (Aethoxysklerol) Study: Results at 2 years , 1995 .
[6] M. Forlee,et al. Stroke after varicose vein foam injection sclerotherapy. , 2006, Journal of vascular surgery.